Skip to content
Open access

Synthesis, Biological Evaluation, and In Silico Studies of Naphtalene‐Hydrazide Derivatives as Dual‐Action Agents for Alzheimer's Disease: Targeting BChE and Oxidative Stress

Sep 2026 · ChemistrySelect · 0 citations · 35 references

TL;DR

Interestingly, compounds 7a and 8a exhibited five‐fold higher selectivity for BChE than AChE, suggesting their potential relevance for further exploration in the context of Alzheimer's disease therapeutics.

Abstract

In this study, the ChE inhibitory effects and antioxidant capacities of newly synthesized naphthohydrazide derivatives ( 4a–9a ) are reported, along with molecular docking and molecular dynamics (MD) simulation results. In enzyme inhibition studies, the synthesized compounds displayed distinct selectivity toward BChE; derivatives 6a, 7a, and 8a (IC 50 : 21.50–22.63 µM) showed strong BChE inhibition, which was closely comparable to that of the reference drug galantamine. In antioxidant assays, compound 7a exhibited exceptional potency in the ABTS radical scavenging assay (IC 50 = 0.04 µM), significantly outperforming the standard reference. SAR analysis indicated that 7a offered an excellent steric fit for the expanded BChE active site, while the bromine atom in 8a established van der Waals interactions within the hydrophobic region, yielding a 5‐fold selectivity for BChE over AChE. Molecular docking further revealed that 7a achieved the lowest binding energies against both AChE (−11.3 kcal/mol) and BChE (−9.4 kcal/mol), forming key interactions with peripheral site residues (Ser125 and Tyr337 of AChE; Ile69 and Thr120 of BChE) and the catalytic triad residue His438 of BChE. Notably, compounds 7a and 8a exhibited five‐fold higher selectivity for BChE than AChE, suggesting their potential relevance for further exploration in the context of Alzheimer's disease therapeutics.

Read PDF

Similar papers

Aug 2026

Design, synthesis, biological activity and computational simulation evaluation of pyrimidine-2-aminoacetamide derivatives as cholinesterase inhibitors

Compound 17v represents a promising lead compound for anti-Alzheimer's therapy and may possess multi-target neuroprotective potential and a favorable preliminary safety profile, supporting its further investigation as a potential therapeutic candidate for Alzheimer’s disease.

Yi-Xuan Wang, Shi-Hao Qin, Qiang Liu et al. · 0 citations
Open access Sep 2026

Design, Synthesis, Antimycobacterial Evaluation, and In Silico Investigation of Benzisothiazole‐Based Hydrazide Derivatives as Potential Anti‐Tuberculosis Agents

Findings highlight the potential of benzisothiazole‐based hydrazide derivatives as promising scaffolds for the development of new antitubercular agents and suggest InhA as a potential molecular target.

V. Sharma, Arun Sharma, Ruchi Poria et al. · 0 citations
Open access Sep 2026

Synthesis, characterization, and integrated in silico studies of 4-Aminoantipyrine-derived Schiff bases as promising antimicrobial, antioxidant, and cytotoxic agents: DFT, ADME, and molecular docking studies

The determined biological activities of Schiff base derivatives obtained from 4-aminoantipyrine via condensation with various aromatic and heteroaromatic aldehydes support these derivatives as promising multifunctional scaffolds for the development of novel antibacterial and anticancer agents.

M. I. Sultan, Muthanna C. Urabee, A. Sadiq et al. · 0 citations
Sep 2026

Synthesis and Biological Evaluation of Imidazo‐Thiadiazole‐Linked Benzisoxazole Hybrids as Dual α ‐Glucosidase and α ‐Amylase Inhibitors With Antioxidant Potential

Findings suggest that the synthesized hybrids represent promising multifunctional candidates for T2DM therapy, combining potent enzyme inhibition, antioxidant activity, and favorable drug‐like profiles.

Mehwish Solangi, Komal Solangi, M. Özil et al. · 0 citations
Open access Sep 2026

Design, Synthesis and Molecular Docking Studies of Some Novel Hydrazone Derivatives Based on Trimetazidine as Selective and Potent AChE Inhibitors

Findings identify trimetazidine‐derived hydrazide‐hydrazones as a promising chemotype for the development of selective AChE inhibitors and provide a basis for further optimization and advanced biological validation.

Muhammed Oğuzhan Doğan, B. Özkan, A. Karaduman et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.